Gallium citrate Ga-67

DB06784ApprovedSmall moleculeRadioactive Diagnostic Agent

Gallium citrate Ga-67 is a radiopharmaceutical agent used in the detection of the presence and extent of Hodgkin's disease, lymphoma, and bronchogenic carcinoma, as well as some acute inflammatory lesions. Although the mechanism is unknown, gallium Ga 67 concentrates in lysosomes and is bound to a soluble intracellular protein in certain viable primary and metastatic tumors and focal sites of inflammation, allowing scintigraphic localization.

Chemical structure of Gallium citrate Ga-67
Mechanism
Curator reviewed
Primary indication
Gallium Citrate Ga 67 Injection may be useful to demonstrate the presence and extent of Hodgkin's disease, lymphoma, and bronchogenic carcinoma.Curator reviewed · 4 structured indications
Formula / weight
C6H5GaO7 · 256.0279 g/mol (avg)
First approval
United States, 1976
Also known as
Gallium (67 Ga) citrate · Gallium (67ga) citrate · Gallium citrate Ga 67 · Gallium-67 Citrate
Brand names
  • Gallium

Resolves to

Structure
InChIKeyYEEGWNXDUZONAA-RYDPDVNUSA-KSMILES[67Ga+3].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O

What you can answer from here — as of July 03, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
12Marketed productsAcross 6 countries and 8 labellers
Sign in
1ATC codeIncluding every combination product, plus 6 drug categories
Sign in
17+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Gallium citrate Ga-67, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account